Park City Group, Inc. (parent of ReposiTrak, Inc.) — Form 10-Q
Reporting period: Fiscal third quarter and nine months ended March 31, 2023; fiscal year ends June 30. The filing is for 2023 Q3, despite the request metadata indicating 2022 Q3. The consolidated results include ReposiTrak’s SaaS supply-chain, compliance, food-safety and B2B marketplace operations.
Financial performance
| Metric | Three months ended March 31, 2023 | Nine months ended March 31, 2023 |
|---|---|---|
| Revenue | $4.82 million; up 6% year over year | $14.30 million; up 6% |
| Operating income | $1.52 million; operating margin 31.5% | $3.93 million; operating margin 27.5% |
| Net income | $1.66 million | $4.21 million |
| Net income applicable to common shareholders | $1.52 million; diluted EPS $0.08 | $3.77 million; diluted EPS $0.20 |
| Operating cash flow | Not provided for the quarter | $7.07 million, versus $4.03 million |
Recurring subscription and support revenue was $4.81 million for the quarter and $14.23 million year to date. For the nine-month period, cost of services was 18% of revenue; sales and marketing was 26%, general and administrative was 24%, and depreciation and amortization was 5%.
Liquidity, debt and capital
- Cash was $22.94 million at March 31, 2023, up $1.48 million from June 30, 2022. Working capital was $22.10 million, and the current ratio was approximately 6.7.
- Current liabilities were $3.88 million, down from $6.10 million, primarily after repayment of the bank line. Bank debt was zero at March 31; total liabilities were $4.36 million, including lease and financing obligations.
- Nine-month investing cash use was $0.90 million, including $0.77 million of capitalized software costs. Financing cash use was $4.68 million, including $2.59 million to reduce the line of credit, $0.98 million for share repurchases, and dividends.
- On April 28, 2023, the company amended its $10 million revolving credit facility, effective March 31. The amendment raised the required liquidity minimum to $12 million and replaced LIBOR with one-month SOFR plus 1.75%. The filing says the facility balance was zero.
Changes, outlook and notable items
- Quarterly revenue rose 6%; operating income increased from $1.18 million to $1.52 million. Nine-month net income rose from $2.91 million to $4.21 million.
- Management attributed recurring revenue growth to demand for food-safety, compliance and supply-chain services. It cited FSMA Section 204 traceability requirements as an opportunity and said it was investing in automation and traceability marketing. The rule requires covered businesses to maintain specified traceability data; the filing describes a proposed two-year compliance timeline.
- Management expects cash, short-term investments and operating cash generation to fund operations and investment needs for at least 12 months, and believes liquidity and operating cash flow will continue to improve. No quantified revenue or earnings guidance is provided.
- General and administrative expense benefited from approximately $1.175 million of Employee Retention Credit payroll-tax refunds, net of fees. This benefit was partly offset by higher bad-debt expense; the cash-flow statement reports $1.2 million of bad-debt expense for the nine months.
- Interest income increased with higher rates, while the prior-year comparison included losses on short-term investments. The filing cautions that rate changes can reduce investment values or income.
- Management noted uncertainty from geopolitical conflicts, banking failures and pandemic-related effects, and said prior PPE-related Marketplace revenue could fluctuate as pandemic demand abates. Management also described rising cybersecurity threats and reported approximately $420,000 of quarterly security, backup, storage and redundancy upgrades, financed through leasing.
- The company declared a quarterly common dividend of $0.015 per share. Series B and Series B-1 preferred stock carries dividends at 7% if paid in cash or 9% if paid in additional preferred shares; preferred dividends totaled $439,833 for the nine months.
- The company repurchased 183,750 shares for approximately $981,000 during the nine months. It reported $9.84 million remaining under its repurchase authorization. Approximately $5.0 million of stock-based compensation obligations remained unrecognized.
Investor verification priorities
- Verify the filing period and issuer identity: this is Park City Group’s consolidated 10-Q, with ReposiTrak as a wholly owned operating subsidiary.
- Assess the sustainability of recurring revenue growth and adoption of the FSMA traceability offering; the filing provides no quantified product-level or customer metrics.
- Review bad-debt exposure and customer collections, including the $1.2 million nine-month bad-debt expense and the receivables allowance.
- Check the amended credit-facility terms and ongoing compliance with its $12 million liquidity and leverage covenants.
- Evaluate earnings quality, including the payroll-tax refund, investment-related gains and losses, preferred dividends, share repurchases and unrecognized stock compensation.